Company profile

Aukera Therapeutics GmbH

Aukera Therapeutics is a spin-off from the Biozentrum of the University of Basel. Our discovery engine enables the development of new classes of pharmaceutical drugs to selectively target different branches of the mTOR pathway.

Highlights

Winner Venture KickWinner Venture Kick

More news about Aukera Therapeutics GmbH

12.10.2022 08:40

Fresh funds to unleash the therapeutic potential of mTOR inhibition

Please login or
register to use the
awards follow feature
21.02.2022 15:50

BaseLaunch invests USD 1.5 million in three new startups

Please login or
register to use the
awards follow feature
Aukera Therapeutics GmbH

Founded
2021

Kanton
BS


LinkedIn

Homepage

rss